ARTICLE | Company News
Ipsogen sales and marketing update
June 2, 2008 7:00 AM UTC
Ipsogen launched its MapQuant Dx Genomic Grade breast cancer diagnostic test. The test, based on a 97-gene expression signature of the tumor, measures tumor grade and assesses tumor proliferation, r...